After Hours
$
77.48
Change
+0.01 +0.01%
Volume
Volume 874,298
Apr 16, 2021, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 76.66
$ 77.47
Change
+0.81 +1.06%
Day low
Day high
$76.82
$77.75

52 week low
52 week high
$71.72
$87.80

Market cap
$193.97B
Average volume
12.59M
P/E ratio
27.88
Rev. per Employee
$648,824
EPS
2.78
Dividend
0.65
Div yield
3.36%
Ex dividend date
3/12/21
MarketWatch News on MRK
-
Long-tenured CEOs can take a business from good to great — and these companies have them
- Lawrence A. Cunningham
-
Johnson & Johnson stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Johnson & Johnson stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains
- MarketWatch Automation
-
Johnson & Johnson stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Johnson & Johnson stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Johnson & Johnson stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Johnson & Johnson stock falls Thursday, underperforms market
- MarketWatch Automation
-
Johnson & Johnson stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Johnson & Johnson stock falls Tuesday, still outperforms market
- MarketWatch Automation
-
Johnson & Johnson stock rises Monday, still underperforms market
- MarketWatch Automation
-
Johnson & Johnson stock underperforms Thursday when compared to competitors
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Analysts Cut Target Prices on MYL Stock after Its Q2 2018 Results
- MarketRealist.com
-
Amgen Stock in May: A Substantial Rise
- MarketRealist.com
-
Analysts’ Recommendations for Merck, Post-1Q18 Results
- MarketRealist.com
Other News on MRK
-
Just Retired? Earn 6% Income With This Bear-Safe Strategy
- Seeking Alpha
-
- Seeking Alpha
-
Don't Move To Cash, Or You'll Regret It
- Seeking Alpha
-
Merck hurt by another setback in its battle against COVID-19
- Seeking Alpha
-
Healthcare Dashboard For April And Focus On IDNA
- Seeking Alpha
-
Nabriva commences exclusive distribution of SIVEXTRO in the U.S.
- Seeking Alpha
-
Merck nixes development plans for MK-7110 in COVID-19
- Seeking Alpha
-
Merck Halts Covid-19 Treatment Trial for Hospitalized Patients
- Jared S. Hopkins
-
3 Top Healthcare Stocks to Buy Right Now
- Motley Fool
- Loading more headlines...
Press Releases on MRK
-
Drug Discovery Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2028
- Market Insight Reports
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com